by aquantum | Sep 19, 2023 | Alhambra, aQNetwork, aQuantum, CDTI, ERDF , Gloin, Grupo Alarcos, Health, Hybrid quantum/classical software systems, Industry-ready quantum solutions, Industry-Ready Software, INUBE, KDM, Life Sciences, Madrija, Ministerio de Ciencia e Innovación, Misiones CDTI, Personalized pharmacogenomics, Q Agnostic, Q Agnostic QAOA, Q ALM, Q Asset Compositor, Q-PGx Model, QHealth, QPath, QSalud, qSOA, Quantum algorithms, Quantum Annealing, Quantum Computing, Quantum Gates, Quantum Programming, Quantum Software, Quantum Software Engineering, Quantum Technology, Quantum workforce, QuantumPath, Research Line, Universidad de Castilla-La Mancha, Universidad de Extremadura
In July 2023, the CDTI (Center for Industrial Technological Development of Spain) carried out the audit of milestone 3 of the “QHealth: Quantum Pharmacogenomics applied to aging” project. On September 15, 2023, the CDTI has issued the “Acta de Comprobación y...
by aquantum | Oct 31, 2022 | Alhambra, Amazon Braket, aQuantum, AWS, Gloin, Grupo Alarcos, Guido Peterssen, Health, Hybrid Classical-Quantum Computing, Industry-ready quantum solutions, INUBE, José Luis Hevia, Life Sciences, Madrija, Mario Piattini, Misiones CDTI, Personalized pharmacogenomics, Q assets compositor, QHealth, QPath, qSOA, Quantum, Quantum Computing, Quantum Programming, Quantum Software, Quantum Software Engineering, Quantum Technology, QuantumPath, Research Line, Software, Universidad de Castilla-La Mancha, Universidad de Extremadura
José Luis Hevia, Guido Peterssen and Mario Piattini, members of aQuantum, have co-authored the article entitled “Quantum Pharmacogenomics with QuantumPath on Amazon Braket” published in The QPath Blog. In this post the authors discuss the characteristics of health and...
by aquantum | Oct 26, 2022 | Alhambra, aQNetwork, aQuantum, CDTI, Gloin, Grupo Alarcos, INUBE, Life Sciences, Madrija, Misiones CDTI, Personalized pharmacogenomics, QHealth, QPath, Quantum Computing, Quantum Programming, Quantum Software, Quantum Software Engineering, Quantum Technology, QuantumPath, Research Line, Software, Universidad de Castilla-La Mancha, Universidad de Extremadura
In October 2022, the CDTI (Center for Industrial Technological Development of Spain) carried out the audit of milestone 2 of the project “QHealth: Quantum Pharmacogenomics applied to aging” and with this event the intense work carried out in QHealth during...
by aquantum | May 21, 2021 | AQCLab, aQuantum, Gloin, Grupo Alarcos, INUBE, Madrija, QPath, Quantum, QuantumPath, Universidad de Castilla-La Mancha, Universidad de Extremadura, University of Coimbra
Members of aQuantum Partner Network (aQNetwork) will be able to experiment and work on the development of their quantum activities with QuantumPath (QPath), the quantum software development and lifecycle application platform. QPath is the first quantum software...
by aquantum | May 10, 2021 | Alhambra, aQuantum, Gloin, Grupo Alarcos, Health, INUBE, Madrija, Misiones CDTI, QHealth, QPath, qSOA, Quality Quantum Software, Quantum, Quantum Annealing, Quantum Computing, Quantum Gates, Quantum Programming, Quantum Technology, QuantumPath, Software, Universidad de Castilla-La Mancha, Universidad de Extremadura
The QHealth project Consortium has selected QuantumPath (QPath) as the quantum platform that will provide the technological support to the “Quantum Pharmacogenomics Applied to Aging” project. It has reached this conclusion after a broad and in-depth comparative study...
by aquantum | May 4, 2021 | Alhambra, Annealing, aQuantum, Gloin, Grupo Alarcos, Health, INUBE, Madrija, Misiones CDTI, QHealth, QPath, Quantum, Quantum Annealing, Quantum Computing, Quantum Gates, Quantum Programming, Quantum Technology, QuantumPath, Software, Universidad de Castilla-La Mancha, Universidad de Extremadura
The first year of the QHealth project: Quantum Pharmacogenomics applied to aging has concluded and we have proceeded to formally close the intense work carried out during this period. The exhaustive review of the state of the art of the pharmacogenetic variables...
Recent Comments